Page last updated: 2024-08-25

zoledronic acid and Carcinoma, Signet Ring Cell

zoledronic acid has been researched along with Carcinoma, Signet Ring Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chow, KU; Engels, K; Kim, SZ; Kriener, S; Mitrou, PS; Trojan, J	1

Other Studies

1 other study(ies) available for zoledronic acid and Carcinoma, Signet Ring Cell

Article	Year
In vitro chemosensitivity to gemcitabine, oxaliplatin and zoledronic acid predicts treatment response in metastatic gastric cancer. Anti-cancer drugs, 2005, Volume: 16, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Deoxycytidine; Diphosphonates; Drug Screening Assays, Antitumor; Gemcitabine; Humans; Imidazoles; Male; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Predictive Value of Tests; Remission Induction; Stomach Neoplasms; Tumor Cells, Cultured; Zoledronic Acid	2005

Article

Year

In vitro chemosensitivity to gemcitabine, oxaliplatin and zoledronic acid predicts treatment response in metastatic gastric cancer.

Anti-cancer drugs, 2005, Volume: 16, Issue:1

Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Deoxycytidine; Diphosphonates; Drug Screening Assays, Antitumor; Gemcitabine; Humans; Imidazoles; Male; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Predictive Value of Tests; Remission Induction; Stomach Neoplasms; Tumor Cells, Cultured; Zoledronic Acid

2005